Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 2 | $5,000,680 |
| Sells | 15 | $537,758 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 18 Mar 2025 17:30 | ALLO | Allogene Therapeutics Inc | CHANG DAVID D | President and CEO | 14 Mar 2025 | Sale | 46,668 | 1.96 | 91,469 | D |
| 18 Mar 2025 17:28 | ALLO | Allogene Therapeutics Inc | BENESKI BENJAMIN MACHINAS | SVP, Chief Technical Officer | 14 Mar 2025 | Sale | 5,488 | 1.975 | 10,839 | D |
| 20 Feb 2025 16:15 | ALLO | Allogene Therapeutics Inc | MESSEMER DEBORAH M. | Director | 18 Feb 2025 | Sale | 13,313 | 2.43 | 32,351 | D |
| 05 Feb 2025 16:16 | ALLO | Allogene Therapeutics Inc | DOUGLAS EARL MARTIN | SVP, General Counsel | 03 Feb 2025 | Sale | 6,404 | 1.71 | 10,951 | D |
| 05 Feb 2025 16:15 | ALLO | Allogene Therapeutics Inc | PARKER GEOFFREY M. | CHIEF FINANCIAL OFFICER | 03 Feb 2025 | Sale | 4,361 | 1.73 | 7,545 | D |
| 05 Feb 2025 16:14 | ALLO | Allogene Therapeutics Inc | MOORE TIMOTHY L. | Chief Technical Officer | 03 Feb 2025 | Sale | 14,746 | 1.71 | 25,216 | D |
| 05 Feb 2025 16:13 | ALLO | Allogene Therapeutics Inc | CHANG DAVID D | President and CEO | 03 Feb 2025 | Sale | 46,003 | 1.68 | 77,285 | D |
| 05 Feb 2025 16:12 | ALLO | Allogene Therapeutics Inc | ROBERTS ZACHARY | EVP of R&D | 03 Feb 2025 | Sale | 18,832 | 1.7 | 32,014 | D |
| 23 Jan 2025 16:30 | ALLO | Allogene Therapeutics Inc | ROBERTS ZACHARY | EVP of R&D | 21 Jan 2025 | Sale | 27,199 | 1.78 | 48,414 | D |
| 10 Dec 2024 16:53 | ALLO | Allogene Therapeutics Inc | MESSEMER DEBORAH M. | Director | 09 Dec 2024 | Sale | 9,136 | 2.18 | 19,916 | D |
| 09 Dec 2024 16:05 | ALLO | Allogene Therapeutics Inc | HUMER FRANZ B | Director | 05 Dec 2024 | Sale | 9,221 | 2.16 | 19,917 | D |
| 20 Jun 2024 16:31 | ALLO | Allogene Therapeutics Inc | MESSEMER DEBORAH M. | Director | 18 Jun 2024 | Sale | 18,641 | 2.2793 | 42,488 | D |
| 03 Jun 2024 16:09 | ALLO | Allogene Therapeutics Inc | HUMER FRANZ B | Director | 30 May 2024 | Sale | 11,200 | 2.3376 | 26,181 | D |
| 20 May 2024 21:33 | ALLO | Allogene Therapeutics Inc | BELLDEGRUN ARIE | Director | 16 May 2024 | Purchase | 1,724,137 | 2.9 | 4,999,997 | I |
| 06 Mar 2024 21:52 | ALLO | Allogene Therapeutics Inc | PARKER GEOFFREY M. | CHIEF FINANCIAL OFFICER | 30 Jan 2024 | Purchase | 190 | 3.595 | 683 | D |
| 20 Dec 2023 16:26 | ALLO | Allogene Therapeutics Inc | MESSEMER DEBORAH M. | Director | 18 Dec 2023 | Sale | 18,640 | 2.6994 | 50,317 | D |
| 09 Aug 2023 16:07 | ALLO | Allogene Therapeutics Inc | MAYO STEPHEN | Director | 07 Aug 2023 | Sale | 10,000 | 4.2855 | 42,855 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)